Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-29

Clinical Trial Update: Comparative Bioavailability Study of Eplerenone 50 mg Tablets Under Fed Conditions [Phase 1]

View source ↗

Summary

This Phase 1 study assessed the comparative bioavailability of eplerenone 50 mg tablets under fed conditions and has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • eplerenone (eplerenone)

Snippet

Sponsor: Sandoz | Conditions: Hypertension | Phase 1 | Status: COMPLETED